Infectious Disease Puscast #15

November 15, 2022

On episode #15 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the previous two weeks, 10/27/22 – 9/9/22.


Hosts: Daniel Griffin and Sara Dong

Click arrow to play
Download Puscast 015 (23 MB .mp3, 38 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of Puscast!

  • Clinical presentation and severity of adenovirus detection alone vs adenovirus co-detection with other respiratory viruses in US children (JPID)
  • Effectiveness of different antimicrobial strategies for staphylococcal prosthetic joint infection (OFID)
  • Clinical impact of ceftriaxone resistance in E. coli bloodstream infections (OFID) 
  • Adjunctive Gentamicin and Rifampin in staphylococcal prosthetic valve Endocarditis (OFID)
  • Diagnostic performance of physician gestalt for bacteremia in patients in the process of being admitted with suspected infection (OFID)
  • Effectiveness of quinolone prophylaxis in pediatric acute leukemia and hematopoietic stem cell transplantation (OFID)
  • Risk factors for Vancomycin drug reaction with Eosinophilia and Systemic symptoms syndrome (JAMA)
  • Prospective evaluation of the fungitell 1>3 beta-d-glucan assay as a diagnostic tool for invasive fungal disease (Wiley)
  • Safety and efficacy of a monoclonal antibody against malaria in Mali (NEJM)
  • Hospitalizations associated with strongyloidiasis in the United States (CID) 
  • Prophylactic benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs (PLOS NTD)
  • Baker’s dozen of top antimicrobial stewardship intervention publications for hospitalized patients (OFID)
  • Baker’s dozen of top antimicrobial stewardship intervention publications in non-hospital care settings in 2021 (OFID)
  • Medical student debt and the US ID workforce (CID)

Music is by Ronald Jenkees

Leave a Reply

Your email address will not be published. Required fields are marked *

Content on this site is licensed by MicrobeTV, Inc. under a Creative Commons Attribution 3.0 License.